A major agency-wide reorganization of the FDA's budget affecting cosmetics, regulatory affairs and medical products, among other elements, was recently proposed by Commissioner Robert M. Califf, M.D. to the Subcommittee of Agriculture, Rural Development, Food and Drug Administration and Related Agencies.

FDA’s FY 2025 budget proposal included more than $12 million to tackle supply chain issues across all product areas, which Califf labeled the FDA’s largest reorganization in its history and will impact nearly half of the agency’s 18,000 employees.

Read more at MedEsthetics >>